Andrea Goren - 14 Jun 2021 Form 3 Insider Report for INVO Bioscience, Inc. (IVF)

Role: Chief Financial Officer
Signature: /s/ Andrea Goren
Issuer symbol: IVF
Transactions as of: 14 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 21 Jun 2021, 18:11:32 UTC
Next filing: 07 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	INVO	Common Stock						12,500	14 Jun 2021	Direct
holding	INVO	Common Stock						45,709	14 Jun 2021	Via Andax LLC
holding	INVO	Common Stock						5,000	14 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INVO	Stock Option							14 Jun 2021	Common Stock	72,500	$5.13	Direct	F2
holding	INVO	Stock Option							14 Jun 2021	Common Stock	162,500	$5.76	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units, which vest in substantially equal monthly increments over a period of 12 months from the grant date of June 14, 2021.
F2	The option will not commence vesting or be exercisable until the Issuer has sufficient shares available under its 2019 Stock Incentive Plan on January 1, 2022 in accordance with the annual increase provisions contained in Section 4.2 thereunder, at which time 12,083 shares underlying the option will vest and the remainder will vest monthly over a 3-year period.
F3	The option vests in monthly increments over a 3-year period from the date of grant.